Awaiting Phase 3 for Luspatercept and ASTX727  Clinical trial accrual is an ongoing challenge in MDS

Awaiting Phase 3 for Luspatercept and ASTX727 Clinical trial accrual is an ongoing challenge in MDS

hematologydebates

2 years
314 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Awaiting Phase 3 for Luspatercept and ASTX727 Clinical trial accrual is an ongoing challenge in MDS at Imedex Great Debates 2018.
Up Next Autoplay